Transcend Capital Advisors LLC trimmed its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 6.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,570 shares of the financial services provider’s stock after selling 185 shares during the period. Transcend Capital Advisors LLC’s holdings in MetLife were worth $210,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. MeadowBrook Investment Advisors LLC increased its holdings in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the period. Carmichael Hill & Associates Inc. increased its holdings in shares of MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the period. Peterson Financial Group Inc. bought a new position in MetLife during the third quarter valued at about $30,000. Retirement Wealth Solutions LLC bought a new position in MetLife during the fourth quarter valued at about $32,000. Finally, Sierra Ocean LLC bought a new position in MetLife during the fourth quarter valued at about $32,000. 94.99% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on MET shares. Barclays decreased their target price on MetLife from $96.00 to $95.00 and set an “overweight” rating for the company in a research note on Friday, February 7th. Wells Fargo & Company raised their target price on MetLife from $92.00 to $97.00 and gave the company an “overweight” rating in a research note on Wednesday, February 19th. TD Cowen raised their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. BMO Capital Markets started coverage on MetLife in a research note on Thursday, January 23rd. They set a “market perform” rating and a $97.00 target price for the company. Finally, JPMorgan Chase & Co. raised their target price on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, MetLife has an average rating of “Moderate Buy” and a consensus target price of $92.58.
MetLife Stock Down 2.1 %
Shares of MetLife stock opened at $81.02 on Monday. The stock has a 50-day moving average price of $83.41 and a 200 day moving average price of $81.53. The company has a market cap of $56.10 billion, a P/E ratio of 13.57, a P/E/G ratio of 0.65 and a beta of 1.07. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.54. MetLife, Inc. has a 1 year low of $67.30 and a 1 year high of $89.05.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. As a group, analysts expect that MetLife, Inc. will post 9.65 EPS for the current fiscal year.
MetLife Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be paid a $0.545 dividend. This represents a $2.18 annualized dividend and a yield of 2.69%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife’s dividend payout ratio is currently 36.52%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Insider Trades May Not Tell You What You Think
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Insider Buying Explained: What Investors Need to Know
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- What is Put Option Volume?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.